FDA & Government News

Diagnoses for Dollars: Kaiser Pays Up

Share

Kaiser Permanente has agreed to a historic $556 million settlement over allegations of fraudulent Medicare Advantage billing practices. The Justice Department's investigation revealed that the company overstated patient illnesses to increase payments, resulting in about $1 billion in improper claims from 2009 to 2018. U.S. Attorney Craig Missakian emphasized the need to protect Medicare from fraud. The civil suits, initiated by multiple whistleblowers, highlight ongoing issues within Medicare Advantage plans regarding patient diagnosis inflation.

Original Source(s)

Related Content